Xwell Inc Stock Fundamentals
| XWEL Stock | USD 1.50 0.05 3.45% |
XWELL Inc fundamentals help investors to digest information that contributes to XWELL's financial success or failures. It also enables traders to predict the movement of XWELL Stock. The fundamental analysis module provides a way to measure XWELL's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to XWELL stock.
XWELL |
XWELL Inc Company Shares Outstanding Analysis
XWELL's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current XWELL Shares Outstanding | 5.26 M |
Most of XWELL's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, XWELL Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, XWELL Inc has 5.26 M of shares currently outstending. This is 97.13% lower than that of the Biotechnology sector and 93.55% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 99.08% higher than that of the company.
XWELL Inc Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining XWELL's current stock value. Our valuation model uses many indicators to compare XWELL value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across XWELL competition to find correlations between indicators driving XWELL's intrinsic value. More Info.XWELL Inc is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value XWELL by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.XWELL Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses XWELL's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of XWELL could also be used in its relative valuation, which is a method of valuing XWELL by comparing valuation metrics of similar companies.XWELL is currently under evaluation in shares outstanding category among its peers.
XWELL Fundamentals
| Return On Equity | -0.76 | ||||
| Return On Asset | -0.16 | ||||
| Profit Margin | (0.64) % | ||||
| Operating Margin | (0.20) % | ||||
| Current Valuation | 3.19 M | ||||
| Shares Outstanding | 5.26 M | ||||
| Shares Owned By Insiders | 9.64 % | ||||
| Shares Owned By Institutions | 17.55 % | ||||
| Number Of Shares Shorted | 71.9 K | ||||
| Price To Book | 1.21 X | ||||
| Price To Sales | 0.23 X | ||||
| Revenue | 30.11 M | ||||
| Gross Profit | 12.05 M | ||||
| EBITDA | (17.23 M) | ||||
| Net Income | (27.74 M) | ||||
| Cash And Equivalents | 71.11 M | ||||
| Cash Per Share | 0.75 X | ||||
| Total Debt | 11.09 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 5.93 X | ||||
| Book Value Per Share | 3.11 X | ||||
| Cash Flow From Operations | (16.07 M) | ||||
| Short Ratio | 6.97 X | ||||
| Earnings Per Share | (3.29) X | ||||
| Price To Earnings To Growth | (0.15) X | ||||
| Target Price | 7.0 | ||||
| Number Of Employees | 266 | ||||
| Beta | 2.47 | ||||
| Market Capitalization | 7.6 M | ||||
| Total Asset | 38.99 M | ||||
| Retained Earnings | (455.85 M) | ||||
| Working Capital | 17.24 M | ||||
| Net Asset | 38.99 M |
About XWELL Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze XWELL Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of XWELL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of XWELL Inc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.XWELL Inc., a health and wellness services company, provides spa services at airports. The company was formerly known as XpresSpa Group, Inc. and changed its name to XWELL Inc. in October 2022. Xwell operates under Personal Services classification in the United States and is traded on NASDAQ Exchange. It employs 363 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out XWELL Piotroski F Score and XWELL Altman Z Score analysis. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of XWELL. If investors know XWELL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about XWELL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of XWELL Inc is measured differently than its book value, which is the value of XWELL that is recorded on the company's balance sheet. Investors also form their own opinion of XWELL's value that differs from its market value or its book value, called intrinsic value, which is XWELL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because XWELL's market value can be influenced by many factors that don't directly affect XWELL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between XWELL's value and its price as these two are different measures arrived at by different means. Investors typically determine if XWELL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, XWELL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.